We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+13.63%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$48.3B
AUM Growth
+$4.2B
(+9.5%)
Cap. Flow
-$749M
Cap. Flow
% of AUM
-1.55%
Top 10 Holdings %
Top 10 Hldgs %
25.22%
Holding
973
New
114
Increased
273
Reduced
385
Closed
131
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$516M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$253M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$210M |
| 4 |
Broadcom
AVGO
|
+$161M |
| 5 |
Uber
UBER
|
+$112M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$340M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$328M |
| 3 |
VMW
VMware, Inc
VMW
|
+$255M |
| 4 |
Chevron
CVX
|
+$187M |
| 5 |
lululemon athletica
LULU
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.57% |
| 2 | Healthcare | 16.39% |
| 3 | Financials | 11.55% |
| 4 | Consumer Discretionary | 10.38% |
| 5 | Industrials | 10.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
AMC Entertainment Holdings
AMC
$2.29B
| – | – |
-42,150
| Closed | -$337K |
|
852
Amylyx Pharmaceuticals
AMLX
$2.65B
| – | – |
-1,700,200
| Closed | -$31.1M |
|
853
Aramark
ARMK
$14.8B
| – | – |
-64,680
| Closed | -$1.62M |
|
854
Arrowhead Research
ARWR
$12.1B
| – | – |
-103,035
| Closed | -$2.77M |
|
855
Acuity Brands
AYI
$10.7B
| – | – |
-3,989
| Closed | -$679K |
|
856
AstraZeneca
AZN
$248B
| – | – |
-719,965
| Closed | -$97.5M |
|
857
Baxter International
BAX
$14.1B
| – | – |
-86,720
| Closed | -$3.27M |
|
858
Brink's
BCO
$4.59B
| – | – |
-57,115
| Closed | -$4.15M |
|
859
BILL Holdings
BILL
$4.68B
| – | – |
-125,100
| Closed | -$13.6M |
|
860
Biomea Fusion
BMEA
$93.3M
| – | – |
-180,000
| Closed | -$2.48M |
|
861
Bristol-Myers Squibb
BMY
$130B
| – | – |
-160,188
| Closed | -$9.3M |
|
862
Boot Barn
BOOT
$5.04B
| – | – |
-170,000
| Closed | -$13.8M |
|
863
Peabody Energy
BTU
$2.9B
| – | – |
-200,000
| Closed | -$5.2M |
|
864
BorgWarner
BWA
$13.7B
| – | – |
-83,706
| Closed | -$3.38M |
|
865
Caterpillar
CAT
$400B
| – | – |
-310,641
| Closed | -$84.8M |
|
866
Crown Holdings
CCK
$13.2B
| – | – |
-347,688
| Closed | -$30.8M |
|
867
COPT Defense Properties
CDP
$4.23B
| – | – |
-52,398
| Closed | -$1.25M |
|
868
Cullinan Oncology
CGEM
$1.07B
| – | – |
-1,150,000
| Closed | -$10.4M |
|
869
CenterPoint Energy
CNP
$26.6B
| – | – |
-627,538
| Closed | -$16.8M |
|
|
CNTB
870
Connect Biopharma Holdings
CNTB
$135M
| – | – |
-650,000
| Closed | -$532K |
|
871
Cogent Biosciences
COGT
$7.09B
| – | – |
-1,036,069
| Closed | -$10.1M |
|
872
CareTrust REIT
CTRE
$9.7B
| – | – |
-425,000
| Closed | -$8.71M |
|
|
873
Chevron
CVX
$370B
| – | – |
-1,108,757
| Closed | -$187M |
|
874
Amdocs
DOX
$6.33B
| – | – |
-100,000
| Closed | -$8.45M |
|
875
DXC Technology
DXC
$1.75B
| – | – |
-203,978
| Closed | -$4.25M |
|
Similar funds
Adage Capital Partners's Q4 2023 Portfolio in Review
As of Q4 2023, Adage Capital Partners held 973 positions worth $48.3B, up 9.5% from $44.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Adage Capital Partners's Q4 2023 filing shows 114 new, 273 increased, 385 reduced and 131 closed positions. Its largest new stake was Uber: 2,148,900 shares worth $132M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $340M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- Adage Capital Partners's largest Q4 2023 buy was Uber: 2,148,900 shares worth $132M.
- Adage Capital Partners added most to Hess in Q4 2023, an estimated $516M increase.
- Adage Capital Partners's biggest Q4 2023 reduction was lululemon athletica, cutting an estimated $124M.
- Adage Capital Partners fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $340M.
- Adage Capital Partners's ten largest holdings make up 25% of its $48.3B portfolio in Q4 2023.
- Adage Capital Partners opened 114 new positions and closed 131 in Q4 2023.
- Adage Capital Partners's portfolio value rose 9.5% quarter-over-quarter to $48.3B.
Based on Adage Capital Partners's 13F filing for Q4 2023, filed 14 Feb 2024.